Rates of perinatal environment risk factors in schizophrenia patients with higher and lower schizophrenia polygenic risk scores

被引：0
|
作者：
Alfimova, M. [1 ]
Gabaeva, M. [1 ]
Lezheiko, T. [1 ]
Plakunova, V. [1 ]
Golimbet, V. [1 ]
机构：
[1] Mental Hlth Res Ctr, Clin Genet Lab, Moscow, Russia
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
10.1192/j.eurpsy.2024.611
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0468
引用
收藏
页码：S293 / S294
页数：2
相关论文
共 50 条
  • [41] Polygenic risk scores for schizophrenia and depression linked to OCD Polygenic prediction of obsessive compulsive symptoms
    Zilhao, N. R.
    Abdellaoui, A.
    Smit, D. J. A.
    Cath, D. C.
    Hottenga, J. J.
    Boomsma, D. I.
    MOLECULAR PSYCHIATRY, 2018, 23 (02) : 168 - +
  • [42] HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Fanelli, Giuseppe
    Kasper, Siegfried
    Kautzky, Alexander
    Zohar, Joseph
    Souery, Daniel
    Montgomery, Stuart
    Albani, Diego
    Ferentinos, Panagiotis
    Rujescu, Dan
    Mendlewicz, Julien
    Serretti, Alessandro
    Fabbri, Chiara
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S207 - S207
  • [43] COMBINING POLYGENIC RISK SCORES ACROSS SEVERAL TRAITS CAN IMPROVE SCHIZOPHRENIA RISK PREDICTION
    Hubert, John
    Walters, James T. R.
    Pardinas, Antonio
    Holmans, Peter
    Pocklington, Andrew
    O'Donovan, Michael
    Escott-Price, Valentina
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S964 - S965
  • [44] Schizotypal Personality Disorder as a Model of Genetic Risk for Schizophrenia: Evidence From Polygenic Risk Scores
    Perez-Rodriguez, M. Mercedes
    Chan, Chi
    Hodgkinson, Colin
    Goldman, David
    Mullins, Niamh
    Vaccaro, Daniel
    Siever, Larry
    Roussos, Panos
    Stahl, Eli
    Hazlett, Erin
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S481 - S481
  • [45] Polygenic Risk Scores, School Achievement, and Risk for Schizophrenia: A Danish Population-Based Study
    Sorensen, Holger J.
    Debost, Jean-Christophe
    Agerbo, Esben
    Benros, Michael E.
    McGrath, John J.
    Mortensen, Preben Bo
    Ranning, Anne
    Hjorthoj, Carsten
    Mors, Ole
    Nordentoft, Merete
    Petersen, Liselotte
    BIOLOGICAL PSYCHIATRY, 2018, 84 (09) : 684 - 691
  • [46] The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review
    Mistry, Sumit
    Harrison, Judith R.
    Smith, Daniel J.
    Escott-Price, Valentina
    Zammit, Stanley
    SCHIZOPHRENIA RESEARCH, 2018, 197 : 2 - 8
  • [47] EVALUATION OF PERINATAL AND PEDIATRIC RISK FACTORS FOR THE DEVELOPMENT OF SCHIZOPHRENIA
    Escamilla, Raul
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 90 - 91
  • [48] Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder
    Ohi, Kazutaka
    Shimada, Mihoko
    Soda, Midori
    Nishizawa, Daisuke
    Fujikane, Daisuke
    Takai, Kentaro
    Kuramitsu, Ayumi
    Muto, Yukimasa
    Sugiyama, Shunsuke
    Hasegawa, Junko
    Kitaichi, Kiyoyuki
    Ikeda, Kazutaka
    Shioiri, Toshiki
    BMJ MENTAL HEALTH, 2024, 27 (01):
  • [49] EFFECTS OF SCHIZOPHRENIA AND BIPOLAR POLYGENIC RISK SCORES ON AGE AT ONSET IN BIPOLAR DISORDER
    Kalman, Janos
    Papiol, Sergi
    Heilbronner, Urs
    Andlauer, Till F. M.
    Anderson-Schmidt, Heike
    Budde, Monika
    Gade, Katrin
    Herms, Stefan
    Forstner, Andreas J.
    Frank, Josef
    Degenhardt, Franziska
    Noethen, Markus
    Rietschel, Marcella
    Falkai, Peter
    Schulze, Thomas
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S967 - S967
  • [50] THE IMPACT OF BIPOLAR AND SCHIZOPHRENIA POLYGENIC RISK SCORES ON FAMILIAL FEATURES OF BIPOLAR DISORDER
    Gade, Katrin
    Papiol, Sergi
    Heilbronner, Urs
    Budde, Monika
    Adorjan, Kristina
    Anderson-Schmidt, Heike
    Kalman, Janos
    Aldinger, Fanny
    Andlauer, Till F. M.
    Schulze, Thomas
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S968 - S968
12345